Kerri-ann Millar - Net Worth and Insider Trading
Kerri-ann Millar Net Worth
The estimated net worth of Kerri-ann Millar is at least $17,698 dollars as of 2024-11-13. Kerri-ann Millar is the CHIEF FINANCIAL OFFICER of Cue Biopharma Inc and owns about 10,472 shares of Cue Biopharma Inc (CUE) stock worth over $17,698. Details can be seen in Kerri-ann Millar's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kerri-ann Millar has not made any transactions after 2021-10-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kerri-ann Millar
Kerri-ann Millar Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kerri-ann Millar owns 1 companies in total, including Cue Biopharma Inc (CUE) .
Click here to see the complete history of Kerri-ann Millar’s form 4 insider trades.
Insider Ownership Summary of Kerri-ann Millar
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CUE | Cue Biopharma Inc | 2021-10-01 | CFO |
Kerri-ann Millar Latest Holdings Summary
Kerri-ann Millar currently owns a total of 1 stock. Kerri-ann Millar owns 10,472 shares of Cue Biopharma Inc (CUE) as of October 1, 2021, with a value of $17,698.
Latest Holdings of Kerri-ann Millar
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CUE | Cue Biopharma Inc | 2021-10-01 | 10,472 | 1.69 | 17,698 |
Holding Weightings of Kerri-ann Millar
Kerri-ann Millar Form 4 Trading Tracker
According to the SEC Form 4 filings, Kerri-ann Millar has made a total of 1 transactions in Cue Biopharma Inc (CUE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Cue Biopharma Inc is the sale of 1,251 shares on October 1, 2021, which brought Kerri-ann Millar around $17,777.
Insider Trading History of Kerri-ann Millar
- 1
Kerri-ann Millar Trading Performance
GuruFocus tracks the stock performance after each of Kerri-ann Millar's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kerri-ann Millar is -42.69%. GuruFocus also compares Kerri-ann Millar's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kerri-ann Millar within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kerri-ann Millar's insider trading performs compared to the benchmark.
Performance of Kerri-ann Millar
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.85 | | | | | |
| Relative Return to S&P 500(%) | 5.85 | | | | | |
Kerri-ann Millar Ownership Network
Ownership Network List of Kerri-ann Millar
Ownership Network Relation of Kerri-ann Millar
Kerri-ann Millar Owned Company Details
What does Cue Biopharma Inc do?
Who are the key executives at Cue Biopharma Inc?
Kerri-ann Millar is the CFO of Cue Biopharma Inc. Other key executives at Cue Biopharma Inc include President and CSO Anish Suri , director & CEO Daniel R Passeri , and Chief Medical Officer Matteo Levisetti .
Cue Biopharma Inc (CUE) Insider Trades Summary
Over the past 18 months, Kerri-ann Millar made no insider transaction in Cue Biopharma Inc (CUE). Other recent insider transactions involving Cue Biopharma Inc (CUE) include a net purchase of 4,000 shares made by Anish Suri , and a net purchase of 3,000 shares made by Daniel R Passeri .
In summary, during the past 3 months, insiders sold 0 shares of Cue Biopharma Inc (CUE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cue Biopharma Inc (CUE) were sold and 7,000 shares were bought by its insiders, resulting in a net purchase of 7,000 shares.
Cue Biopharma Inc (CUE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cue Biopharma Inc Insider Transactions
Kerri-ann Millar Mailing Address
Above is the net worth, insider trading, and ownership report for Kerri-ann Millar. You might contact Kerri-ann Millar via mailing address: 40 Guest Street, Boston Ma 02135.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
